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Abstract
The HAD superfamily contains enzymes that catalyze carbon or phosphate transfer
reactions. One family within the HAD superfamily is the p-nitrophenyl phosphatase (PNPPase)
family. Members of this family are all phosphatases that cleave the substrate analog pnitrophenyl phosphate, in addition to their biologically significant substrate. Interestingly,
among the small number of family members that have been characterized, there is a wide variety
of biologically relevant activities. YZGD from Paenibacillus thiaminolyticus has pyridoxal
phosphatase activity, catalyzed by a HAD superfamily domain, as well as a CDP-alcohol/sugar
nucleotide hydrolase activity, catalyzed by a Nudix hydrolase domain. Determining the structure
of this enzyme would result in valuable information to contribute to our knowledge and
understanding of the HAD superfamily and the Nudix hydrolase superfamily. Sufficient
quantities of sufficiently pure YZGD are necessary to perform x-ray crystal structure
determination. A histidine tag was added to the enzyme so that it can be purified by nickel
affinity chromatography. This was done by cloning the gene into pET19b, a plasmid containing
a sequence encoding a string of ~10 histidines, and expressing the protein in Escherichia coli
BLR(DE3). The tagged YZGD expresses well, is soluble, and retains full activity. It appears to
be completely purified by nickel affinity chromatography. This will now allow YZGD to be
purified in large quantities, crystallized, and its structure determined.
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Introduction

The HAD superfamily, named for haloacid dehalogenase (the first enzyme discovered for
the superfamily), contains a remarkable variety of enzymes. Members are found in all three
domains of life, and include dehalogenases, sugar phosphomutases, phosphonatases, ATPases,
and phosphoesterases. There are 33 major enzyme families within the HAD superfamily, the
majority of which are phosphoesterase families. At least five of the HAD superfamily proteins
exist in all three domains of life, indicating that they were present in the last universal common
ancestor of all life on earth (Burroughs, et al. 2006). HAD superfamily enzymes share a version
of the Rossmanoid α/β fold, which has alternating β-α units that form a three-layered α/β
“sandwich.” One unique feature of the HAD superfamily fold is that it contains two sites in
which additional domains, or “caps,” can be inserted. These caps distinguish between different
families within the HAD superfamily, and often provide important structural or functional
residues. Members of the superfamily can contain caps in both sites, a cap in only one site, or no
caps at all. (Figure 1). (Burroughs et al. 2006)

Figure 1: The classic HAD motif, showing the Rossmanoid fold and
the positions in which caps can be inserted. (Burroughs et al. 2006)
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The active site of the HAD superfamily members is surrounded by four loops. All
superfamily members use an aspartate residue, located on loop 1, to catalyze a carbon or
phosphoryl group transfer. The phosphotransferases within the superfamily all require a Mg2+
cofactor, which is coordinated by two carboxylate residues from loop 4. The phosphoryl group
of the substrate interacts with either a serine or threonine on loop 2, and a lysine or arginine on
loop 3. (Allen and Dunaway-Mariano 2004)

Figure 2: The important active site residues of HAD superfamily
phosphotransferases (Allen and Dunaway-Mariano 2004).

One interesting family found within the HAD superfamily is the p-nitrophenyl
phosphatase family (PNPPase) (Koonin & Tatusov 1994). The first members identified were
enzymes from two species of yeast, Saccharomyces cerevisiae and Schizosaccharomyces pombe
(Attias & Bonnet 1972; Yang et al. 1991). These two enzymes were found to hydrolyze pnitrophenyl phosphate, which is a substrate analog not found in biological systems, but thus far,
no biologically relevant substrate has been found for these two enzymes. A large number of
putative proteins have a high level of sequence similarity to the known family members, but only
a few of these proteins have been characterized. Despite the small number of enzymes that have
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been characterized, a variety of activities have been found within this family (Figure 2). NAGD
from Escherichia coli is a family member that hydrolyzes uridine 5’-monophosphate (UMP)
(Tremblay et al. 2006; Tirrell, I.M., Nguyen, A.T., Mentz, R.J., Slivka, E.J. and O’Handley, S.F.
unpublished data). There are homologues of NAGD in other organisms as well, including
Shigella, Salmonella, and Yersinia pestis (Figure 3). There are characterized pyridoxal
phosphatases (PLPases) in the family: YZGD PLPase from Paenibacillus thiaminolyticus, which
also contains a Nudix hydrolase domain (Tirrell et al. 2006), and PLPases found in humans and
mice (Jang et al. 2007). Phosphoglycolate phosphatases (PGPases) are also found in this family;
the two that have been characterized are from Chlamydomonas reinhardtii (a green algae)
(Mamedov et al. 2001) and Staphylococcus aureus (Hill, J.K., Thomson, J.G., Strassner, A.M.,
and O’Handley, S.F., in preparation). The PGPase from S. aureus has been shown to be a
virulence factor (Begun et al. 2005), indicating its significance in the cell.
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S cerevisiae PNPPase
S pombe PNPPase
C reinhardtii PGPase
S aureus PGPase
NAGD UMPase
YZGD PLPase
H sapiens PLPase

----------------------MTAQQGVPIKITNKEIAQEFLDKYDTFLFDCDGVLWLG
----------------------------MAKKLSSPKEYKEFIDKFDVFLFDCDGVLWSG
MLSLKQLPSARCAARPVRPVRRMVAAQASARPIATNEQKLELLKKVECFIFDCDGVIWLG
------------------------------------------MKQYKAYLIDLDGTMYMG
-------------------------------------------MTIKNVICDIDGVLMHD
----------------------------------------MLFDAFDVFLFDLDGVIYVG
---------------------------MARCERLRGAALRDVLGRAQGVLFDCDGVLWNG
. * ** .

38
32
60
18
17
20
33

S cerevisiae PNPPase
S pombe PNPPase
C reinhardtii PGPase
S aureus PGPase
NAGD UMPase
YZGD PLPase
H sapiens PLPase

SQALPYTLEILDLLKQLGKQLIFVTNNSTKSRLAYTKKFASFGID-VKEEQIFTSGYAPA
SKPIPGVTDTMKLLRSLGKQIIFVSNNSTKSRETYMNKINEHGIA-AKLEEIYPSAYSSA
DKVIEGVPETLDMLRGMGKKVFFVTNNSTKSRAGYMSKFQSLGLN-VKAEEIYSSSYAAA
TDEIDGAKQFIDYLNVKGIPHLYVTNNSTKTPEQVTEKLREMHID-AKPEEVVTSALATA
NVAVPGAAEFLHGIMDKGLPLVLLTNYPSQTGQDLANRFATAGVD-VPDSVFYTSAMATA
PEALPGAVEALERLRSGGKTIRFLTNNPCMTREQTAARLNRLGIE-AAKDEVISSGWATA
ERAVPGAPELLERLARAGKAALFVSNNSRRARPELALRFARLGFGGLRAEQLFSSALCAA
.
. .
*
..*
.
.
*
*

97
91
119
77
76
79
93

S cerevisiae PNPPase
S pombe PNPPase
C reinhardtii PGPase
S aureus PGPase
NAGD UMPase
YZGD PLPase
H sapiens PLPase

VYIRDFLKLQ-PGKDKVWVFGESGIGEELKLMGYESLGGADSRLDTPFDAAKSPFLVNGL
TYVKKVLKL--PADKKVFVLGEAGIEDELDRVGVAHIGGTDPSLRR--ALASEDVEKIGP
AYLESINFN-----KKVYVIGETGILEELDLKGIRHVGGPGD-ADKKVTLKSGEFMEH-DYISEQSPGAS-----VYMLGGSGLNTALTEAGLVIKN---------------------DFLRRQEGKK------AYVVGEGALIHELYKAGFTITD---------------------CCLRERRAGS------VYVLGDEHLERECRDAGLDIVD---------------------RLLRQRLPGPPDAPGAVFVLGGEGLRAELRAAGLRLAG--------------DPSAGDGA
.
... *
.
*

156
147
171
110
108
111
139

S cerevisiae PNPPase
S pombe PNPPase
C reinhardtii PGPase
S aureus PGPase
NAGD UMPase
YZGD PLPase
H sapiens PLPase

DKDVSCVIAGLDTKVNYHRLAVTLQYLQK-DSVHFVGTNVDS-TFPQKGYTFPGAGSMIE
DPSVGAVLCGMDMHVTYLKYCMAFQYLQD-PNCAFLLTNQDS-TFPTNGKFLPGSGAISY
DHDVGAVVVGFDRYVNYYKIQYATLCIRENPGCMFIATNRDAVTHLTDAQEWAGNGSMVG
DEHVDYVVIGLDEQVTYEKLAIATLGVRN--GATFISTNPDVSIPKERGF-LPGNGAITS
-VNPDFVIVGETRSYNWDMMHKAAYFVAN--GARFIATNPDT----HGRGFYPACGALCA
VNAAEAVVVGWSDDLTLRDIQSAVTRIAN--GAQFIATNADWSFPGPDGP-MMAVGTAVE
APRVRAVLVGYDEHFSFAKLREACAHLRD-PECLLVATDRDPWHPLSDGSRTPGTGSLAA
*. *
.
.
. *. *
. *.

214
205
231
167
161
168
198

S cerevisiae PNPPase
S pombe PNPPase
C reinhardtii PGPase
S aureus PGPase
NAGD UMPase
YZGD PLPase
H sapiens PLPase

SLAFSSNRRPSYCGKPNQNMLNSIISAFNLDRSKCCMVGDRLNTDMKFGVEGGLGGTLLV
PLIFSTGRQPKILGKPYDEMMEAIIANVNFDRKKACFVGDRLNTDIQFAKNSNLGGSLLV
AIVGSTKREPIVVGKPSDFMLKNISASLGLRPDQIAMVGDRLDTDIMFGKNGGLA-TALV
VVSVSTGVSPQFIGKPEPIIMVKALEILGLDKSEVAMVGDLYDTDIMSGINVGMD-TIHV
GIEKISGRKPFYVGKPSPWIIRAALNKMQAHSEETVIVGDNLRTDILAGFQAGLE-TILV
AIKMASGKTPYIVGKPYPYMFRQALQHV-EDWSRAVMFGDTPDADIAGAHRIGIS-AVLI
AVETASGRQALVVGKPSPYMFECITENFSIDPARTLMVGDRLETDILFGHRCGMT-TVLT
.
.
***
.
**
*. .
. .

274
265
290
226
220
226
257

S cerevisiae PNPPase
S pombe PNPPase
C reinhardtii PGPase
S aureus PGPase
NAGD UMPase
YZGD PLPase
H sapiens PLPase

LSGI---ETEERTLKISHDYPRPKFYIDKLGDIYALTNNEL--LTGV---SKEEEILEKDAP-VVPDYYVESLAKLAETA------LSGV---TTP-EVLNSPDNKVHPDFVLNSLPDLLSVKEKAMVAA
QTGV------STLEDVQNKNVPPTYSFKDLNEAIAELEK----LSGVS------SLDDIDSMPFRPSWIYPSVAEIDVI-------SSGP------YTGYSSARDYRKPDAIIPDL-------------LTGVSRLEEAQAYLAAGQHDLVPHYYVESIADLTEGLED----.*
*
.

312
298
330
259
250
250
296

Figure 2: Multiple sequence alignment of known enzymes of the P7PPase family. Amino
acids that are conserved are marked by characters below the sequences (‘*’ represents
identical amino acids, and ‘.’ represents similar amino acids). Residues conserved within
all HAD superfamily members are highlighted in gray. The enzyme names are indicated to
the left. YZGD has been truncated to show only its HAD superfamily domain (the first 250
amino acids), omitting the domain containing the 7udix signature sequence for clarity.
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E_coli
Shigella
Salmonella
Y_pestis
Shewanella

MTIKNVICDIDGVLMHDNVAVPGAAEFLHGIMDKGLPLVLLTNYPSQTGQDLANRFATAGVDV
MTIKNVICDIDGVLMHDNVAVPGAAEFLHGIMDKGLPLVLLTNYPSQTGQDLANRFATAGVDV
MTIKNVICDIDGVLMHDNVAVPGAAEFLTGILEKGLPLVLLTNYPSQTGQDLANRFATAGVNV
MTIKSVICDIDGVLLHDNTAIKGANDFLARIQDAGMPLVILTNYPSQTAQDLTNRFITAGLDV
--MKNIICDIDGVLLHDNKLIPGSDKFIHRVLDQGNPLVILTNYPVQTGKDLQNRLSAAGIDV
**.* .********.*** . *. *. . . * ***.***** **. ** **
**. *

E_coli
Shigella
Salmonella
Y_pestis
Shewanella

PDSVFYTSAMATADFLRRQEGKKAYVVGEGALIHELYKAGFTITDVNPDFVIVGETRSYNWDM
PDSVFYTSAMATADFLRRQEGKKAYVVGEGALIHELYKAGFTITDVNPDFVIVGETRSYNWDM
PDSVFYTSAMATADFLRRQEGKKAYVVGEGALIHELYKAGFTITDVNPDFVIVGETRSYNWDM
PESAFYTSAMATADFLRRQDGKKAYVIGEGALVHELYKAGFTITDINPDFVIVGETRSYNWDM
PEECFYTSAMATADFLKHQEGSKAFVIGEGALTHELYKAGFTITDINPDFVIVGETRSYNWDM
*. ************..*.* **.*.***** ************.*****************

E_coli
Shigella
Salmonella
Y_pestis
Shewanella

MHKAAYFVANGARFIATNPDTHGRGFYPACGALCAGIEKISGRKPFYVGKPSPWIIRAALNK
MHKAAYFVANGARFIATNPDTHGRGFYPACGALCAGIEKISGRKPFYVGKPSPWIIRAALNK
MHKAAFFVANGARFIATNPDTHGRGFYPACGALCAGIEKISGRKPFYVGKPSPWIIRAALNK
MHKAAYFVANGARFIATNPDSHGHGFAPACGALCAPIEKISGRKPFYVGKPSPWIIRAALNK
IHKAAGFVARGARFIATNPDTHGPAYSPACGALCSPIERITGKKPFYVGKPSSWIIRSALNH
.**** *** **********.** .. *******. **.*.*.********* ****.***.

E_coli
Shigella
Salmonella
Y_pestis
Shewanella

MQAHSEETVIVGDNLRTDILAGFQAGLETILVLSGVSSLDDIDSMPFRPSWIYPSVAEIDVI
MQAHSEETVIVGDNLRTDILAGFQAGLETILVLSGVSSLDDIDSMPFRPSWIYPSVAEIDVI
MQAHSEETVIVGDNLRTDILAGFQAGLETILVLSGVSTINDIDSMPFRPSWIYPSVAEIDVI
MQAHSESTVIVGDNLRTDILAGFQAGLETILVLSGVSTLTDIDAMPFRPSYVYPSVADIDII
INGHSENTVIIGDNMRTDILAGFQAGLETILVTSGVSKLEDIDKEPFRPNHVFACAGDIDVV
...*** ***.***.***************** **** * *** **** .. ....**..

Figure 3: Alignment of homologues of 7AGD in pathogenic bacteria. Identical amino acids
are indicated by a ‘*’ and similar amino acids are indicated by a ‘.’.
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YZGD is a particularly interesting member of the PNPPase family because, in addition to
YZGD’s HAD domain responsible for its PLPase activity, it has a second domain containing the
signature sequence of the Nudix hydrolase superfamily responsible for its activity on CDPalcohols, ADP-sugars, and to a limited extent GDP-sugars and UDP-sugars (Tirrell et al. 2006).
The Nudix hydrolase superfamily contains diverse enzymes that hydrolyze nucleotide derivatives
and are found in a variety of organisms (McLennan 2006). Therefore, the crystal structure of
YZGD would be interesting to those who study the various Nudix hydrolases, in addition to
those interested in the HAD superfamily.
In early 2006, the structure of the human PLPase family member was determined (PDB
ID: 2CFT). The structure of YZGD could be compared to this structure to seek out similarities
in structure that lead to specific PLPase activity. It would be the first structure of a prokaryotic
PLPase in the HAD superfamily, as well as the first structure of an enzyme with dual
phosphatase and Nudix hydrolase activity.
The yzgd gene has previously been subcloned into a pET plasmid and used to transform
E. coli HMS174(DE3). The YZGD protein has been shown to have good expression levels and
solubility. Purification included sonication to break open the cells, streptomycin to remove the
nucleic acids, ammonium sulfate fractionation, size exclusion chromatography, and anion
exchange chromatography (Tirrell et al. 2006).
The goal of this project was to work out conditions that would increase the amount and
purity of YZGD to be used in x-ray crystallography, since a high yield of pure protein is
necessary for x-ray crystal structure determination. It was proposed to scale up the expression
and purification to obtain milligram quantities of protein to work with. Expression was
originally carried out at 37°C, however the expression temperature was lowered to 15°C to
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increase both expression and solubility; this technique has been successful for a number of other
proteins in the lab. Purification was modified, from using gravity chromatography to “FPLC”
columns on the HPLC, for higher resolution in protein purification. The success of each
purification step was measured using SDS-PAGE to evaluate purity, Bradford assays to quantify
protein, and enzyme assays to determine specific activity. However, scaling up expression,
lowering expression temperature, and modifying the chromatography procedures still did not
yield pure enough YZGD, thus we created a His•tagged protein and carried out affinity
chromatography purification. Here we show that we have successfully created a subclone that
expresses soluble His•tagged YZGD, and that we can purify it to an essentially pure state via
affinity chromatography.
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Materials and Methods

YZGD expression and purification
Cell culture and expression
The YZGD protein was expressed in Escherichia coli HMS174(DE3) cells (Novagen)
containing the pETYZGD plasmid. The cells were grown in Luria-Bertani media with 100µg/ml
ampicillin at 37°C until they reached an A600 of 0.6. The cultures were induced to express the
protein with 1mM isopropyl β-D-thiogalactoside. Expression was conducted under two
conditions, to determine which would produce the greatest yield of soluble protein. In the first
condition, the culture was incubated at 37°C, induced, then incubated for 3 more hours at 37°C,
after which the cells were harvested. Alternatively, the culture was cooled from 37°C to 15°C,
induced, and incubated for 24 hours at 15°C before harvesting.

Cell harvesting and sonication
Cells were harvested by centrifugation, washed with buffered saline, centrifuged again
and stored at -80°C. Prior to sonication, cells were thawed and resuspended in two volumes of
TED buffer (50mM Tris-HCl (pH 7.5), 1mM EDTA, 0.1mM DTT). Cells were broken open by
sonication using a Branson sonifier, and the resulting solution was centrifuged to remove the
insoluble proteins and cell debris from the soluble protein in the supernatant.

Streptomycin fractionation
Streptomycin sulfate was added to the sonicated supernatant to a concentration of 1%
(w/v) and incubated, with stirring, for 15 minutes on ice. This was centrifuged to remove the
precipitant containing nucleic acids.
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Ammonium sulfate fractionation and concentration
Saturated ammonium sulfate was added to the resulting supernatant to a concentration of
55%, and incubated on ice for 15 minutes. The precipitate, containing YZGD, was obtained by
centrifugation and resuspended in TED buffer.

Size exclusion chromatography
Size exclusion chromatography was conducted at room temperature, using the GE
Healthcare HiPrep™ Sephacryl™ S-200 16/60 column, which has a volume of 120 ml of resin.
All solvents were filtered, degassed, and sparged with helium to eliminate dissolved oxygen.
The column buffer used contained 50mM Tris-HCl pH 7.5, 0.1mM DTT, 1mM EDTA, and 0.2M
NaCl.
The column was equilibrated with 2 column volumes of column buffer. The protein
sample (concentrated to less than 2ml) was loaded onto the column and the mobile phase was run
at 0.5 ml/min. Fractions of 1ml were collected and monitored at 280nm and 290nm.

Dialysis
Prior to ion exchange chromatography, the protein sample was dialyzed to lower the salt
concentration. Dialysis was performed with Pierce Slide-A-Lyzer dialysis cassettes with a 10kD
molecular weight cutoff (MWCO) membrane. The dialysis buffer contained 50mM tris-HCl
(pH 7.5) and 1mM EDTA. The sample was dialyzed for 6 hours, transferred to fresh buffer, then
dialyzed for an additional 12 hours.
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Ion exchange chromatography
FPLC Method
Buffer A contained Tris-HCl (pH 7.5) and 1mM EDTA. Buffer B contained TrisHCl (pH 7.5), 1mM EDTA, and 1M NaCl. Buffers were filtered, degassed, and sparged
with helium.
The GE Healthcare HiTrap™ Sepharose™ DEAE (Diethylaminoethyl) FF 1ml
column was used. The column was washed with 5ml each of water, Buffer A, Buffer B,
then Buffer A, at 1ml/min flow rate. The sample was loaded onto the column, and 1ml
fractions were collected. The column was washed with 5ml of Buffer A.
YZGD was eluted with either a 20ml gradient from 0M NaCl (Buffer A) to 0.5M
NaCl in Buffer A, or a stepwise elution was carried out where 5ml each of the following
salt concentrations were run consecutively over the column: 0M, 0.1M, 0.2M, 0.3M,
0.4M, 0.5M NaCl.
Gravity Method
Buffer A contained 50mM Tris-HCl (pH 7.5) and 1mM EDTA. Additional
buffers were made with the following NaCl concentrations: 0.1M, 0.2M, 0.25M, 0.3M,
0.4M, and 0.5M, in addition to 50mM Tris-HCl (pH 7.5) and 1mM EDTA.
A 5ml DEAE Sepharose column was equilibrated with ~120ml of buffer A.
Dialyzed protein sample (4.5ml) was applied to the column, and fraction collection
began, collecting ~2ml fractions. Sequentially, 8ml of each buffer was applied over the
column, from the lowest to the highest NaCl concentration.
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Protein Analysis
The Bradford protein assay (Bradford 1976) was used to determine protein concentration
throughout the purification process. Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) using a stacked gel (Laemmli 1970) was used to examine the purity and quantity
of YZGD.
Enzymatic activity assays were conducted to determine the levels of active YZGD
protein. A standard reaction mixture contained 50mM Tris-Maleate (pH 5.0), 5mM MgCl2,
1mM dithiothreitol, and 4mM pyridoxal phosphate (PLP). Between 0.5 and 4.0 units of YZGD
were added to 50µl of the reaction mix. Reactions were incubated at 37°C for 30 minutes, and
quenched by the addition of 50µl of 4 parts 20% packed Norit to 1 part 7% perchloric acid.
After centrifugation, 50µl of the supernatant was analyzed for phosphate using the method of
Ames and Dubin.

YZGD His•tag Subcloning, Expression and Purification
Plasmid Purification
The pETYZGD and pET19b (HisTag) plasmids were purified from overnight cultures of
E. coli BLR(DE3) as described in Sambrook and Russell. The cells were disrupted by alkaline
lysis using a NaOH/SDS solution, the chromosomal DNA was precipitated, and the cell extract
was treated with RNase A and incubated at 37°C to degrade RNA. Phenol:chloroform was used
to further purify the cell extract, and the plasmid DNA was precipitated with ethanol at -80°C.
The sample was centrifuged, the ethanol discarded, and the DNA pellet was dried and
resuspended in water. The DNA was further purified by a polyethylene glycol (PEG)-NaCl
precipitation overnight on ice, using a 6.5% PEG and 0.8M NaCl solution to remove the tRNA.
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DNA concentration was determined by measuring the absorbance at 260nm, and both
concentration and purity were verified by gel electrophoresis.

Restriction Enzyme Digests
The yzgd gene was excised from the pETYZGD plasmid by digesting with NdeI and BlpI
restriction enzymes (New England Biolabs). The pET19b plasmid was also digested with NdeI
and BlpI to create matching “sticky” ends. After verification by gel electrophoresis that the
digests were complete, the excised gene and the plasmid were gel-purified. This involved
running each sample on a 0.7% agarose gel, staining with ethidium bromide, and physically
cutting the appropriate band out of the gel. The DNA was extracted from the gel using the Geneclean® kit (MPBiomedicals). The concentration of DNA was estimated using gel
electrophoresis and DNA standards.

Ligation
The yzgd gene was ligated into the pET19b plasmid using T4 DNA ligase (Invitrogen).
Several ratios of plasmid:gene were used. The ligations were conducted at 15°C for 24 hours.

Transformation
E. coli DH5α competent cells (Invitrogen) were transformed with each of the ligation
mixtures. Transformed cells were grown on LB plates containing 100 μg/ml ampicillin to select
for cells containing the pET19YZGD plasmid (and therefore the ampicillin resistance gene).
Plasmids were purified according to the procedure in Sambrook and Russell, to determine
whether they were successful recombinants. Overnight cultures were grown from colonies and
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plasmids were purified from the cultures. The isolated plasmids were examined using gel
electrophoresis to determine which colonies contained the recombinant plasmids
(pET19YZGD(HisTag)).

Verification
As an additional verification step, the purified plasmids were digested using BamHI
(New England Biolabs) and again run on a gel. There is a BamHI site in pET19YZGD but not in
pET19b digested with NdeI and BlpI, so the recombinant plasmid will appear as primarily linear
DNA on the gel, while the pET19b plasmid will still be a supercoiled plasmid or a smaller linear
band if not digested fully prior to ligation.
Once successfully transformed cells were identified, several were used to create freezer
stocks for future use. One freezer stock was used to create an overnight culture for a plasmid
purification, and this plasmid DNA was used to transform BLR(DE3) competent cells (Novagen)
to be used for expression. Freezer stocks were made of the expression cell line as well.

Expression
A 100ml culture of pET19YZGD(HT) in E. coli BLR(DE3) cells was prepared for
expression. As a control, a culture of pETYZGD in HMS174(DE3) was grown under identical
conditions. Expression, harvesting, and sonication were performed simultaneously in the two
cultures, in the same manner as the experiments described earlier. After sonication, the cell
extracts were tested for protein concentration and enzymatic activity. The samples were dialyzed
in 20mM Tris-HCl (pH 8.0) to prepare them for the nickel affinity column chromatography.
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Affinity Chromatography Purification
Nickel Affinity resin from Novagen was used to make two 1ml columns for affinity
purification, one for the His•tagged protein and one for the untagged control. Each column was
equilibrated with Binding Buffer, containing 20mM Tris-HCl (pH 8.0), 5M NaCl, and 5mM
imidazole. After column equilibration, the protein sample was loaded and fractions were
collected. The column was washed with 5ml Wash Buffer to elute all other proteins, which
contained a higher imidazole concentration than Binding Buffer (60mM imidazole) but was
otherwise the same. Next, 5ml Elution Buffer (250mM imidazole) was used to elute the bound
His•tagged YZGD protein.
To determine the contents of each fraction, the protein concentration and enzymatic
activity were measured, and fractions containing protein were run on a SDS polyacrylamide gel
to examine each fraction and the purity of the eluted His•tagged YZGD protein.
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Results and Discussion

YZGD expression and purification
The YZGD enzyme was first expressed and purified using the same methods as described
in Tirrell et al. (2006). Table 1 and the protein gel in Figure 5 show the results of this initial
purification. This protein came from a 2L batch of E. coli HMS(174) cells incubated at 37°C
during expression of YZGD. The dark, wide band in lane 2 shows that the protein overexpressed
successfully. However, throughout the purification steps, there were many other contaminating
proteins remaining. This lead to the decision to express the protein at 15°C, with hope that it
would express better and be more soluble. This has been the case with a number of other
proteins studied in the lab.

Figure 5: Purification of YZGD protein expressed at 37°C. Lane 1: molecular
weight markers, Lane 2: crude extract, Lane 3: sonicated supernatant, Lane 4:
streptomycin fractionation supernatant, Lane 5: 55% ammonium sulfate fraction,
Lane 6: size exclusion pooled fractions, Lane 7: ion exchange pooled fractions.
Some contaminating proteins were eliminated during each step of purification, but
the final sample still contained many proteins other than YZGD.
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Table 1: Purification of YZGD protein expressed at 37°C.
Volume
(ml)

Activity
(units/ml)

Total
units

[Protein]
(mg/ml)

Specific
activity
(units/mg)

Total
protein
(mg)

Sonication

11.9

9.57

114

8.69

1.10

103

Ammonium
sulfate 55%

1.28

56.7

72.3

23.9

2.37

30.5

Size Exclusion
Chromatography

10.7

0.952

10.2

1.31

0.727

14.0

Ion Exchange
Chromatography

7.00

Step

1.50

10.5

When expressed at 15°C versus 37°C, the expression level of YZGD was comparable, or
slightly better at 15°C as seen in Figure 6 (compare lane 3 to lane 7). As a negative control,
samples of cells containing only the expression vector pET11b (and therefore not expressing
YZGD) were included on the gel.

Figure
6: Comparison
of expression
protein from
pETYZGD
in E.the
colichange in
While
expressing
at a lower
temperatureof
didYZGD
not significantly
increase
expression,
HMS174(DE3), 15°C vs 37°C. Lane 1: molecular weight markers, Lane 2: 37°C
pETYZGD
prior to induction,
3: 37°C
3 hoursinafter
induction,
expression
temperature
from 37°CLane
to 15°C
led topETYZGD
a significantatincrease
solubility.
AfterLane
4: 37°C pET11b prior to induction, Lane 5: 37°C pET11b at 3 hours after induction,
Lane 6: 15°C
pETYZGD
prioropen
to induction,
Lane 7: 15°C
pETYZGD
at 24
hoursand
after
sonicating
the cells
to break them
and centrifugation
to remove
insoluble
proteins
other
induction, Lane 8: 15°C pET11b prior to induction, Lane 9: 15°C pET11b at 24 hours
after induction.
was successfully
at both 37°C and 15°C.
cellular
debris, mostYZGD
of the protein
YZGD protein
was presentexpressed
in the supernatant.
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While expressing at a lower temperature did not significantly increase expression, the
change in expression temperature from 37°C to 15°C led to a significant increase in solubility.
After sonicating the cells to break them open and centrifugation to remove insoluble proteins and
other cellular debris, most of the YZGD protein was present in the supernatant.

Figure 7: Comparison of solubility of YZGD protein, expressed at 15°C vs 37°C. Lane
1: 15°C crude extract, Lane 2: 15°C freeze thaw supernatant, Lane 3: 15°C freeze thaw
pellet, Lane 4: 15°C sonicated supernatant, Lane 5: 15°C sonicated pellet, Lane 6: 37°C
crude extract, Lane 7: 37°C sonicated supernatant, Lane 8: 37°C sonicated pellet, Lane
9: 15°C pET11b control sonicated supernatant, Lane 10: molecular weight markers.
YZGD expressed at 15°C is mostly in the sonicated supernatant, indicating greater
solubility compared to the protein expressed at 37°C.
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Purification of the protein expressed at 15°C included the steps shown in Figure 8.
YZGD did not elute from the cells in a freeze-thaw step, and thus the pellet from this step was
processed, as it contained YZGD. A portion of YZGD was found to be soluble upon sonication,
and the sonicated supernatant was processed further. Streptomycin removed nucleic acid (DNA)
from the sample. Two rounds of anion exchange chromatography using a DEAE FPLC column
from GE Healthcare removed some contaminating proteins from YZGD, but not enough to
render YZGD pure. A gravity DEAE anion exchange column further purified YZGD, but still
not enough for the enzyme to be pure enough to crystallize for x-ray crystal structure
determination. Thus we decided to tackle the problem from a new perspective, to create a
His•tagged protein and purify this tagged protein by nickel affinity chromatography.

Figure 8: Purification of YZGD protein expressed at 15°C. Lane 1: crude extract,
Lane 2: freeze-thaw pellet, Lane 3: sonicated supernatant, Lane 4: streptomycin
supernatant, Lane 5: FPLC ion exchange fraction, Lane 6: 55% ammonium sulfate
fraction, Lane 7: FPLC ion exchange fraction, Lane 8: dialyzed fraction, Lane 9:
gravity ion exchange fraction, Lane 10: molecular weight markers. The final protein
sample (lane 9) was not sufficiently pure for x-ray crystal structure determination.
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Table 2: Purification of YZGD protein expressed at 15°C.
Step
Sonication
Streptomycin fraction
Ion Exchange
Chromatography
Ammonium Sulfate
Fractionation and
Dialysis
Ion Exchange
Chromatography

Volume
(ml)
2.45

Activity*
(units/ml)
31.2

Total
activity*
(units)
76.4

[Protein]
(mg/ml)
17.8

Specific
activity*
(units/mg)
1.75

Total
protein
(mg)
43.6

4.00

6.70

26.8

6.00

1.77

10.6

2.40

2.98

7.15

4.50

Gravity Ion Exchange
Chromatography

0.350

*

Detailed activity information was not determined for many steps of this procedure,
because the purity of YZGD was not good enough to support using this procedure to
prepare samples for crystallography.

YZGD His•tag subcloning and purification
Since the purification of YZGD proved ineffective, it was decided that a His•tag would
be added to the protein. This sequence of histidines, attached to one end of the protein, would
allow it to bind to Ni2+ ions. Therefore, the cell extract could be run over a nickel affinity
column, and when the bound protein is eluted, it should be pure YZGD. The pET19b His•tag
expression vector was used. The map of this vector is shown in Figure 9, with the chosen
restriction enzyme target sites marked by red rectangles. Computational analysis showed that the
yzgd gene did not contain either of these sites, so the same restriction enzymes could be used
both to excise yzgd out of pETYZGD and to digest the pET19b plasmid, giving them “sticky”
ends that can be ligated together easily.
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Figure 9: pET19b plasmid map. Red rectangles indicate the digestion sites for
the selected restriction enzymes.
(http://www.emdbiosciences.com/docs/ADIS/TB049-000.pdf)
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Plasmid Purification
The pET19b and pETYZGD plasmids were each purified from E. coli DH5α cells. The
amount of plasmid DNA obtained was calculated from the absorbance of the solution at 260nm,
using the following equation:
DAA Concentration (ng/µl) = A260(OD) · 50(ng · µl-1 · OD-1) · dilution factor
where the dilution factor was 100. The total DNA was calculated by multiplying the
concentration by 120 µl since that is the volume of plasmid obtained. The concentration and
purity were verified qualitatively by gel electrophoresis (Fig. 10). The intensity of the band of
obtained plasmid matches the control band.

Table 3: Quantification of isolated pET19b and pETYZGD.
A260 of
[DAA]
Total DAA
Sample
1:100
(ng/µl)
(µg)
dilution
pET19b
0.047
235
28.2
pETYZGD
0.041
205
24.6

a

b

Figure 10: Agarose gel electrophoresis of purified pET19b and pETYZGD.
a) pET19b purification. Lane 1: λ HindIII molecular weight markers, Lane 2: 100ng
pET19b, Lane 3: 100ng pET11b control.
b) pETYZGD purification. Lane 1: λ HindIII molecular weight markers, Lane 2:
100ng pETYZGD, Lane 3: 100ng pET11b control.
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Digestion and purification
The pET19b plasmid was digested with BlpI and NdeI restriction enzymes.
Simultaneously, single digests were prepared with each of the enzymes. After 1 hour of
digestion, these single digests were run on a 0.7% agarose gel alongside the undigested plasmid,
for comparison (Fig. 11a). Since the BlpI sample still contained some undigested plasmid, the
digestion was allowed to proceed. After 2.5 hours (Fig. 11b), both samples appeared to be
completely digested, and it was safe to assume that the double digest had also been successful.

a

b

Figure 11: Digestion of pET19b by BlpI and AdeI.
a) Results after 1 hour. b) Results after 2.5 hours. Lane 1: λ HindIII molecular weight
markers, Lane 2: undigested pET19b, Lane 3: pET19b digested by AdeI, Lane 4:
pET19b digested by BlpI. While the BlpI digestion was not complete at 1 hour, both
reactions appeared to be complete by 2.5 hours.
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The same procedure was conducted with the pETYZGD plasmid, to excise the yzgd gene
from the plasmid. After 1 hour, the two single digests of pETYZGD were analyzed by gel
electrophoresis (Fig. 12). The majority of the DNA was linear, digested plasmid, but there was
still a small fraction of remaining undigested plasmid. The digestions were allowed to proceed
for a total of 2.5 hours to complete digestion (Fig. 14).

Figure 12: Digestion of pETYZGD by BlpI and AdeI, after 1 hour. Lane 1: λ HindIII
molecular weight markers, Lane 2: pETYZGD digested by AdeI, Lane 3: pETYZGD
digested by BlpI, Lane 4: undigested pETYZGD. There was still a small amount of
undigested plasmid after 1 hour which was completely digested after 2.5 hours.
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The digested pET19b plasmid was run in one large lane on a gel to be cut out for
purification, as shown in Figure 13. Only one band is visible because the fragment excised
between the two restriction sites is so small (~60 bases) that it would have quickly run off of this
gel. Unfortunately, this means that any plasmids that were only digested once will be similar in
size to the plasmids that were completely digested, and will not be separated in the gel, hence the
importance of the single digest controls shown above. The band is consistent with the 5.7kb size
of the pET19b plasmid.

Figure 13: Gel purification of digested pET19b plasmid DAA. Lane 1: λ HindIII
molecular weight markers, Lane 2: 1µl of digested pET19b, Lane 3: rest of digested
pET19b. The band was cut from the gel for purification.
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Digested pETYZGD was also run on a gel for purification (Fig. 14). The bottom band is
the yzgd gene, to be cut out of the gel for purification. This is consistent with the known size of
the yzgd gene, approximately 1.2kb The YZGD gene is well separated from the plasmid DNA
for ease in purification.

Figure 14: Gel purification of yzgd gene from digested pETYZGD plasmid DAA. Lane
1: λ HindIII molecular weight markers, Lane 2: 1µl of digested pETYZGD, Lane 3: rest
of digested pETYZGD. The bottom band, which is the yzgd gene, was cut from the gel
for purification.
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The concentration of purified plasmid was determined by gel electrophoresis. Two
different volumes of plasmid, 1µl and 2µl, were run alongside 100ng of pET11b plasmid. The
bands were visually compared to the control to estimate the concentration. For pET19b, shown
in Figure 15, the 2µl band was comparable to the 100ng control. Therefore, the concentration
was determined to be approximately 50ng/µl.

Figure 15: Quantitation of purified digested pET19b plasmid. Lane 1: λ HindIII
molecular weight markers, Lane 2: 1µl pET19b, Lane 3: 2µl pET19b, Lane 4: 100ng
pET11b for comparison. By comparison to the band of known concentration, the
pET19b solution appears to be about 50ng/µl.
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The same procedure was followed to quantitate the yzgd DNA (Fig. 16). In this case, the
2µl band was about half the intensity of the 100ng control band. Therefore, there were
approximately 50ng of DNA in the 2µl band, and the concentration was estimated at 25ng/µl.

Figure 16: Quantitation of purified excised yzgd gene. Lane 1: λ HindIII molecular
weight markers, Lane 2: 1µl yzgd, Lane 3: 2µl yzgd, Lane 4: 100ng pET11b for
comparison. By comparison to the band of known concentration, the yzgd solution
appears to be about 25ng/µl.
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Ligation and Transformation
As shown in Table 4, varying amounts of the purified yzgd were added to the digested
pET19b plasmid, and ligated together to form a new recombinant plasmid. The resulting
plasmids were transformed into E. coli DH5α cells and grown on selective LB plates containing
100 μg/ml ampicillin. The number of colonies that grew is also shown in Table 4. The colonies
resulting from ligation E, the negative control to which no yzgd gene was added, indicate that
some pET19b plasmids were not completely doubly digested, and re-ligated to themselves.
However, the other ligations yielded 4-10 times more colonies, an initial indication that the
subcloning was probably successful.

Table 4: Ligations of pET19b with yzgd, and results of transformation into E. coli DH5α
cells. pET19b = 5500bp, yzgd = 1239bp
Ligation
A
B
C
D
E
pUC control

pET19b
(ng)
200
200
200
200
200
---

yzgd
(ng)
6.25
12.5
25
50
0
---
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pET19b:yzgd
ratio
2.4
1.2
0.6
0.3
-----

# colonies
13
16
37
15
4
~160

Twelve colonies were chosen from ligations A-D, grown as overnight cultures in LB
media, and plasmids were isolated from these cultures. The isolated plasmids were analyzed by
gel electrophoresis to determine if they were the new recombinant pET19bYZGD plasmid. This
is shown in Figure 17. Plasmid DNA from colonies A2 and B2 was consistent in size with the
pET19b plasmid, which reinforces the earlier assumption that some fraction of the pET19b
plasmids were only digested by one of the two restriction enzymes and were ligated back
together. Colony A1 contains a smaller unknown DNA. All other colonies appeared to be of the
correct size to contain the new pET19YZGD plasmid.

Figure 17: Purified plasmids from transformations of E. coli DH5α with pET19b-YZGD
ligation mixtures. Lane 1: λ HindIII molecular weight markers, Lane 2: pET19b
control, Lanes 3-14: purified plasmid from colonies A1, A2, B1, B2, C1, C2, C3, C4, C5,
C6, D1, D2. Colonies B1, C1, C2, C3, C4, C5, C6, D1, D2 contain plasmids larger than
pET19b, indicating that they probably contain pET19YZGD.
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To verify the success of subcloning, the isolated plasmids were digested with BamHI.
The pET19b plasmid contains a single BamHI site, which is cut out when cloning the yzgd gene
into the plasmid. Since the yzgd gene itself contains a BamHI restriction site, the
pET19YZGD(HT) plasmid should be digested by BamHI to produce a linear plasmid. Figure 18
confirms the results shown in Figure 17. A1 contains a plasmid too small to be
pET19YZGD(HT). A2 and B2 contain undigested pET19b (a small amount is relaxed or
digested plasmid (upper band) but a majority is supercoiled plasmid (lower band)). The rest of
the colonies appear to contain pET19YZGD(HT) which can be digested by BamHI. The
overnight culture made from colony C6 was streaked to single colonies, and a single colony from
this plate was cultured and used to make a freezer stock.

Figure 18: Purified plasmids from transformations of E. coli DH5α with pET19b-YZGD
ligation mixtures, digested with BamH1. Lane 1: λ HindIII molecular weight markers,
Lane 2: pET19b control, Lanes 3-14: digested plasmids from colonies A1, A2, B1, B2,
C1, C2, C3, C4, C5, C6, D1, D2. Colonies B1, C1, C2, C3, C4, C5, C6, D1, D2 appear to
contain mostly digested, linear plasmid of the predicted correct size, indicating that they
contain pET19YZGD.
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The recombinant pET19YZGD(HT) plasmid was isolated from the transformed E. coli.
As with the plasmid purifications described earlier, the concentration of isolated DNA was
determined by measuring its absorbance at 260nm (Table 5) and verified by gel electrophoresis
(Fig. 19).

Table 5: Amount of isolated pET19YZGD(HT) DAA.
Sample
pET19YZGD(HT)

A260 of
1:100
dilution
0.048

[DAA]
(ng/µl)

Total DAA
(µg)

240

28.8

Figure 19: Purified pET19YZGD(HT) plasmid. Lane 1: λ HindIII molecular weight
markers, Lane 2: 100ng pET19YZGD, Lane 3: 100ng pET19b, Lane 3: 100ng pET11b
as a control. All of the samples appear pure, and of the same quantity.
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Expression
The isolated pET19YZGD(HT) was used to transform E. coli cells for expression, and
freezer stocks were made. The new tagged protein and the original untagged protein (as a
control) were overexpressed simultaneously. Figure 20 shows the results of this expression. The
expression level of the His•tagged protein was comparable to that of the untagged protein,
possibly higher. An increase in expression level could be because different strains of E. coli
were used to express the protein. The BLR(DE3) cells used to express the tagged protein may be
more effective than the HMS(174) strain used for the pETYZGD.

Figure 20: Comparison of expression: YZGD protein from pETYZGD plasmid in E. coli
HMS174(DE3) vs YZGD(HT) protein from pET19YZGD(HisTag) plasmid in E. coli.
Lane 1: molecular weight markers, Lane 2: expression of pET19YZGD(HT) prior to
induction, Lane 3: expression of pET19YZGD(HT) at 24 hours after induction, Lane 4:
expression of pETYZGD prior to induction, Lane 5: expression of pETYZGD at 24
hours after induction. The His•tagged YZGD expressed just as well as the untagged
YZGD, indicating that the tag does not interfere with expression.
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The solubility of the tagged and untagged YZGD was ascertained by analyzing the
protein composition of the sonicated supernatants and pellets by SDS-PAGE (Figure 21). The
solubility level of the His•tagged YZGD protein was satisfactory, with ~50% of the tagged
protein being present in the supernatant after sonication and centrifugation (lane 8).

Figure 21: Comparison of solubility: YZGD protein from pETYZGD plasmid in E. coli
HMS174(DE3) vs YZGD(HT) protein from pET19YZGD(HT) plasmid in E. coli. Lane
1: molecular weight markers, Lane 2: pETYZGD freeze thaw pellet, Lane 3: pETYZGD
freeze thaw supernatant, Lane 4: pETYZGD sonicated supernatant, Lane 5: pETYZGD
sonicated pellet, Lane 6: pET19YZGD(HT) freeze thaw pellet, Lane 7:
pET19YZGD(HT) freeze thaw supernatant, Lane 8: pET19YZGD(HT) sonicated
supernatant, Lane 9: pET19YZGD(HT) sonicated pellet. Both the untagged and tagged
protein show good solubility, with a significant portion of the YZGD protein located in
the supernatant after sonication.
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The protein concentration of the sonicated supernatant of each culture was measured, and
is recorded in Table 6. The total protein in pET19YZGD(HT) in BLR(DE3) was nearly double
that of the total protein in pETYZGD in HMS174(DE3). This could be due to the use of
different E. coli strains or to better expression or solubility of YZGD.
Likewise, the enzymatic activity was analyzed for each culture. The pET19ZGD(HT) in
BLR(DE3) culture had more than double the activity as compared to pETYZGD in
HMS174(DE3), measured in units per mg of total protein. Each unit is one nanomole of
substrate cleaved per minute. The increase in activity is most likely due to the increased
solubility of the protein described above.

Table 6: Concentration and enzymatic activity of tagged and untagged enzymes.
Sample
YZGD
YZGD(HT)

Volume
(ml)
1.06
1.038

Activity
(units/ml)
8.26
35.0

Total
units
8.76
36.3
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[Protein]
(mg/ml)
6.5
11.5

Specific
activity
(units/mg)
1.27
3.05

Total
protein
(mg)
6.9
11.9

Affinity Purification
A pilot affinity chromatography purification experiment was performed to verify that this
method would effectively purify the His•tagged protein. Simultaneous experiments were
performed using the tagged and untagged protein, and the results are shown in Figure 22. When
extract containing untagged YZGD was loaded onto the nickel column, proteins washed through
the column. The band of overexpressed YZGD is clearly visible in these fractions. When the
elution buffer was used, no other proteins were eluted from the columnm indicating that no
proteins had bound to the nickel-containing resin. In the case of the His•tagged YZGD (lanes 15), many proteins eluted in the wash fractions, but little, if any, YZGD(HT) eluted in this stage.
When elution buffer was applied, YZGD(HT) was eluted from the column, and appears to be
pure as seen in lanes 4 and 5 of Figure 22.

Figure 22: Ai-ATA affinity chromatography of tagged and untagged proteins. Lane 1:
YZGD(HT) wash fraction 1, Lane 2: YZGD(HT) wash fraction 2, Lane 3: YZGD(HT)
wash fraction 3, Lane 4: YZGD(HT) elution fraction 1, Lane 5: YZGD(HT) elution
fraction 2, Lane 6: YZGD wash fraction 1, Lane 7: YZGD wash fraction 2, Lane 8:
YZGD wash fraction 3, Lane 9: YZGD elution fraction 1, Lane 10: YZGD elution
fraction 2. The untagged YZGD protein washes through the column immediately, while
the tagged YZGD(HT) binds to the column until eluted, essentially devoid of other
proteins.
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Conclusions

The first purification methods for YZGD, involving size exclusion and ion exchange
chromatography, were insufficient for obtaining protein pure enough for x-ray crystallography.
While these methods had previously been used to purify the enzyme for determination of its
substrate and quantitation of activity, the methods did not yield enough pure protein for
crystallography. Adding a histidine tag to YZGD before evaluating its activity would have been
unwise, since this modification might have altered the enzyme’s activity in some way that we
would have been unaware of. However, since the activity of YZGD has now been thoroughly
evaluated (Tirrell et al. 2006), any change in activity could be detected.
The tagged YZGD(HT) protein has been shown to have good expression and solubility.
It also appears to purify very effectively over a nickel affinity chromatography column, and
retains its enzymatic activity throughout all of these steps, with a final specific activity
comparable to the purified untagged YZGD. Since this work, Julian Ramos has scaled up
expression and purification to obtain a larger amount of the YZGD protein. He also obtained
excellent purification and activity. The next step in the project is the crystallization of the
protein with the help of our collaborator, Dr. Joseph Wedekind from the University of Rochester.
It is possible that the tag will need to be removed from the protein before it will successfully
crystallize into its native structure. The crystallization process will be considerably easier now
that there is a simple and effective way to purify large amounts of YZGD protein.
The eventual determination of the three-dimensional structure of YZGD will be
important to scientists who study HAD superfamily enzymes, as well as those who study Nudix
hydrolase enzymes. The structure of YZGD can be compared to known PLPase structures
within the nitrophenyl phosphatase (PNPPase) family of the HAD superfamily, PNPPase family
members with other substrates, HAD superfamily members not in the PNPPase family, and
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Nudix hydrolases. As more enzymes are characterized, in terms of both activity and structure, it
becomes easier to identify features that determine substrate specificity. For these reasons, the
structure of YZGD will be of great value.
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